- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fischer enjoys record fourth quarter
Record fourth quarter sales and earnings helped Fischer Imagingfinish its 1995 fiscal year with a flourish. The Denver-based x-ray vendor reported fourth-quarter earnings(end-December) of $1.5 million and $23 million in sales, bothcompany records.
Record fourth quarter sales and earnings helped Fischer Imagingfinish its 1995 fiscal year with a flourish.
The Denver-based x-ray vendor reported fourth-quarter earnings(end-December) of $1.5 million and $23 million in sales, bothcompany records. Revenues were up 25% from the same period of1994.
For the 1995 fiscal year, Fischer reported net earnings of$2.3 million on the strength of $76.8 million in sales. The performancewas a notable improvement over fiscal 1994, when the company lost$5.6 million on sales of $68.5 million. CEO Morgan Nields attributedthe turnaround to an improved sales mix and global sales growth,as well as gains made through OEM deals and internal cost-cuttingmeasures.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
